Eva Döring

493 total citations
9 papers, 373 citations indexed

About

Eva Döring is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Eva Döring has authored 9 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Organic Chemistry and 2 papers in Pharmacology. Recurrent topics in Eva Döring's work include Melanoma and MAPK Pathways (5 papers), Quinazolinone synthesis and applications (3 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). Eva Döring is often cited by papers focused on Melanoma and MAPK Pathways (5 papers), Quinazolinone synthesis and applications (3 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). Eva Döring collaborates with scholars based in Germany, Netherlands and Switzerland. Eva Döring's co-authors include Stefan Laufer, Marcel Günther, Michael Juchum, Michael Lämmerhofer, Adrian Sievers‐Engler, Pierre Koch, Daniel Rauh, Hannah L. Tumbrink, Jonas Lategahn and Julian Engel and has published in prestigious journals such as Journal of Medicinal Chemistry, Molecules and European Journal of Medicinal Chemistry.

In The Last Decade

Eva Döring

9 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Döring Germany 9 232 187 97 94 55 9 373
Roberta Tesch Germany 14 263 1.1× 217 1.2× 76 0.8× 78 0.8× 63 1.1× 20 520
Chau Almaden United States 4 227 1.0× 135 0.7× 84 0.9× 42 0.4× 38 0.7× 4 356
Chia-Ning Yang Taiwan 12 380 1.6× 274 1.5× 158 1.6× 48 0.5× 39 0.7× 14 668
Mingsong Shi China 14 261 1.1× 131 0.7× 114 1.2× 27 0.3× 30 0.5× 58 470
Mingxing Teng United States 12 394 1.7× 315 1.7× 127 1.3× 38 0.4× 33 0.6× 24 661
Hossam Nada South Korea 12 235 1.0× 158 0.8× 93 1.0× 28 0.3× 66 1.2× 46 454
Stuart C. Wilson United Kingdom 10 305 1.3× 208 1.1× 147 1.5× 53 0.6× 19 0.3× 14 555
Takumitsu Machida Japan 8 192 0.8× 141 0.8× 143 1.5× 47 0.5× 57 1.0× 10 361
Marion Peyressatre France 6 258 1.1× 72 0.4× 157 1.6× 100 1.1× 29 0.5× 8 482
Kazuhiro Fukasawa Japan 11 345 1.5× 183 1.0× 203 2.1× 57 0.6× 75 1.4× 19 538

Countries citing papers authored by Eva Döring

Since Specialization
Citations

This map shows the geographic impact of Eva Döring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Döring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Döring more than expected).

Fields of papers citing papers by Eva Döring

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Döring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Döring. The network helps show where Eva Döring may publish in the future.

Co-authorship network of co-authors of Eva Döring

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Döring. A scholar is included among the top collaborators of Eva Döring based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Döring. Eva Döring is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Tesch, Roberta, Tatu Pantsar, Eva Döring, et al.. (2019). Pyridinylimidazoles as dual glycogen synthase kinase 3β/p38α mitogen-activated protein kinase inhibitors. European Journal of Medicinal Chemistry. 175. 309–329. 26 indexed citations
2.
Santo, Renan Fernandes do Espírito, Lucas Silva Abreu, Eva Döring, et al.. (2019). Natural chromones as potential anti-inflammatory agents: Pharmacological properties and related mechanisms. International Immunopharmacology. 72. 31–39. 42 indexed citations
3.
Förster, Michael, A. Chaikuad, Eva Döring, et al.. (2018). Development, Optimization, and Structure–Activity Relationships of Covalent-Reversible JAK3 Inhibitors Based on a Tricyclic Imidazo[5,4-d]pyrrolo[2,3-b]pyridine Scaffold. Journal of Medicinal Chemistry. 61(12). 5350–5366. 44 indexed citations
4.
Bauer, Silke M., Eva Döring, Adrian Sievers‐Engler, et al.. (2017). Design, Synthesis, and Biological Evaluation of Novel Type I 1 / 2 p38α MAP Kinase Inhibitors with Excellent Selectivity, High Potency, and Prolonged Target Residence Time by Interfering with the R-Spine. Journal of Medicinal Chemistry. 60(19). 8027–8054. 24 indexed citations
5.
Günther, Marcel, Jonas Lategahn, Michael Juchum, et al.. (2017). Trisubstituted Pyridinylimidazoles as Potent Inhibitors of the Clinically Resistant L858R/T790M/C797S EGFR Mutant: Targeting of Both Hydrophobic Regions and the Phosphate Binding Site. Journal of Medicinal Chemistry. 60(13). 5613–5637. 81 indexed citations
6.
Döring, Eva, et al.. (2017). From 2-Alkylsulfanylimidazoles to 2-Alkylimidazoles: An Approach towards Metabolically More Stable p38α MAP Kinase Inhibitors. Molecules. 22(10). 1729–1729. 8 indexed citations
7.
Juchum, Michael, Marcel Günther, Eva Döring, et al.. (2017). Trisubstituted Imidazoles with a Rigidized Hinge Binding Motif Act As Single Digit nM Inhibitors of Clinically Relevant EGFR L858R/T790M and L858R/T790M/C797S Mutants: An Example of Target Hopping. Journal of Medicinal Chemistry. 60(11). 4636–4656. 61 indexed citations
8.
Döring, Eva, Adrian Sievers‐Engler, Andreas Lange, et al.. (2016). Tri- and Tetrasubstituted Pyridinylimidazoles as Covalent Inhibitors of c-Jun N-Terminal Kinase 3. Journal of Medicinal Chemistry. 60(2). 594–607. 44 indexed citations
9.
Günther, Marcel, Silke M. Bauer, Eva Döring, et al.. (2014). Tetra-Substituted Pyridinylimidazoles As Dual Inhibitors of p38α Mitogen-Activated Protein Kinase and c-Jun N-Terminal Kinase 3 for Potential Treatment of Neurodegenerative Diseases. Journal of Medicinal Chemistry. 58(1). 443–456. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roberta Tesch Breakdown of academic impact, for papers by Chau Almaden Breakdown of academic impact, for papers by Chia-Ning Yang Breakdown of academic impact, for papers by Mingsong Shi Breakdown of academic impact, for papers by Mingxing Teng Breakdown of academic impact, for papers by Hossam Nada Breakdown of academic impact, for papers by Stuart C. Wilson Breakdown of academic impact, for papers by Takumitsu Machida Breakdown of academic impact, for papers by Marion Peyressatre Breakdown of academic impact, for papers by Kazuhiro Fukasawa
Rankless by CCL
2026